Bloomberg "Anywhere" Remote Login Bloomberg "Terminal" Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last kr5.80 SEK
Change Today 0.00 / 0.00%
Volume 0.0
As of 12:00 PM 09/2/15 All times are local (Market data is delayed by at least 15 minutes).

pharmalundensis ab (PHAL) Snapshot

Open
kr5.70
Previous Close
kr5.80
Day High
kr5.80
Day Low
kr5.70
52 Week High
09/19/14 - kr11.00
52 Week Low
04/14/15 - kr5.00
Market Cap
101.6M
Average Volume 10 Days
2.5K
EPS TTM
kr-0.33
Shares Outstanding
17.5M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for PHARMALUNDENSIS AB (PHAL)

Related News

No related news articles were found.

pharmalundensis ab (PHAL) Related Businessweek News

No Related Businessweek News Found

pharmalundensis ab (PHAL) Details

PharmaLundensis AB operates as a pharmaceutical company in Sweden. It is conducting clinical research, which has completed Phase I and Phase IIa clinical stages for developing drug for the treatment of chronic obstructive pulmonary disease. The company was founded in 2006 and is based in Lund, Sweden.

Founded in 2006

pharmalundensis ab (PHAL) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

pharmalundensis ab (PHAL) Key Developments

PharmaLundensis AB, Annual General Meeting, Jun 17, 2015

PharmaLundensis AB, Annual General Meeting, Jun 17, 2015.

PharmaLundensis AB to Report First Half, 2015 Results on Aug 20, 2015

PharmaLundensis AB announced that they will report first half, 2015 results on Aug 20, 2015

PharmaLundensis AB to Report Q1, 2015 Results on May 21, 2015

PharmaLundensis AB announced that they will report Q1, 2015 results on May 21, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PHAL:SS kr5.80 SEK 0.00

PHAL Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for PHAL.
View Industry Companies
 

Industry Analysis

PHAL

Industry Average

Valuation PHAL Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PHARMALUNDENSIS AB, please visit www.pharmalundensis.se. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.